These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 12934978

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial.
    Lagae L, Buyse G, Ceulemans B.
    Seizure; 2005 Jan; 14(1):66-71. PubMed ID: 15642504
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Levetiracetam as adjunctive therapy for refractory anxiety disorders.
    Kinrys G, Worthington JJ, Wygant L, Nery F, Reese H, Pollack MH.
    J Clin Psychiatry; 2007 Jul; 68(7):1010-3. PubMed ID: 17685735
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A.
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [Abstract] [Full Text] [Related]

  • 47. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
    Chaisewikul R, Privitera MD, Hutton JL, Marson AG.
    Cochrane Database Syst Rev; 2001 May; (1):CD001901. PubMed ID: 11279737
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE, Benbadis S, Edrich P, Tassinari CA, Hirsch E.
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Effectiveness and safety of topiramate in treatment-resistant bipolar disorder].
    Vieta E, Gilabert A, Rodríguez A, García-Castrillón A, Luna MJ, Arrufat E, García-Parés G.
    Actas Esp Psiquiatr; 2001 Jul; 29(3):148-52. PubMed ID: 11412488
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Clinical experience with levetiracetam for adults with epilepsy].
    Barcs G, Szucs A.
    Ideggyogy Sz; 2007 Jan 20; 60(1-2):31-4. PubMed ID: 17432091
    [Abstract] [Full Text] [Related]

  • 58. Role of high-dose levetiracetam as add-on therapy for intractable epilepsy: case report and brief review of the literature.
    Mateo-Carrasco H, Serrano-Castro PJ, Molina-Cuadrado E, Goodwin M, Nguyen TV, Kotecha PN.
    Int J Clin Pharm; 2015 Aug 20; 37(4):559-62. PubMed ID: 25822041
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.